Syros Pharmaceuticals (SYRS) Insider Trading & Ownership $1.96 +0.02 (+1.03%) (As of 10/4/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Syros Pharmaceuticals (NASDAQ:SYRS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.26%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$4.21 MNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$203,946.09 Get SYRS Insider Trade Alerts Want to know when executives and insiders are buying or selling Syros Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SYRS Insider Buying and Selling by Quarter Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Syros Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/12/2024Jason HaasCFOBuy45,344$1.68$76,177.92 9/10/2024Conley CheeCEOBuy50,000$1.51$75,500.00 9/10/2024Jason HaasCFOBuy35,363$1.55$54,812.65 6/28/2024Richard A YoungDirectorSell34,837$5.12$178,365.44 4/2/2024David RothInsiderSell150$4.98$747.00 12/21/2023Srinivas AkkarajuDirectorBuy904,977$4.42$3,999,998.34 12/6/2023David RothInsiderSell6,287$3.95$24,833.65 (Data available from 1/1/2013 forward) SYRS Insider Trading Activity - Frequently Asked Questions Who is on Syros Pharmaceuticals's Insider Roster? The list of insiders at Syros Pharmaceuticals includes Conley Chee, David Roth, Eric R Olson, Jason Haas, Richard A Young, Srinivas Akkaraju, and Timothy Tyson. Learn more on insiders at SYRS. What percentage of Syros Pharmaceuticals stock is owned by insiders? 12.26% of Syros Pharmaceuticals stock is owned by insiders. Learn more on SYRS's insider holdings. Which Syros Pharmaceuticals insiders have been buying company stock? The following insiders have purchased SYRS shares in the last 24 months: Conley Chee ($75,500.00), Jason Haas ($130,990.57), and Srinivas Akkaraju ($3,999,998.34). How much insider buying is happening at Syros Pharmaceuticals? Insiders have purchased a total of 1,035,684 SYRS shares in the last 24 months for a total of $4,206,488.91 bought. Which Syros Pharmaceuticals insiders have been selling company stock? The following insiders have sold SYRS shares in the last 24 months: David Roth ($54,605.25), Eric R Olson ($2,411.50), and Richard A Young ($178,365.44). How much insider selling is happening at Syros Pharmaceuticals? Insiders have sold a total of 49,311 Syros Pharmaceuticals shares in the last 24 months for a total of $235,382.19 sold. More Insider Trading Tools from MarketBeat Related Companies: Cue Biopharma Insider Transactions Pyxis Oncology Insider Transactions Enanta Pharmaceuticals Insider Transactions Amylyx Pharmaceuticals Insider Transactions Rezolute Insider Transactions MacroGenics Insider Transactions Atai Life Sciences Insider Transactions Cabaletta Bio Insider Transactions Atossa Therapeutics Insider Transactions Shattuck Labs Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders Are Betting Big on These 2 StocksThis Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are Buying This page (NASDAQ:SYRS) was last updated on 10/5/2024 by MarketBeat.com Staff From Our PartnersThe panic button has already been pressedIf you missed it, my emergency election broadcast is now available on replay.Porter & Company | SponsoredHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.Monument Traders Alliance | SponsoredThe Bible Says it Clear As DayIt came to me clear-as-day thanks to the Bible… in the Parable of Talents, in the book of Matthew… This pa...Prosperity Research | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored“A very dark day is coming to America”Wall Street Legend on Economy: "If you knew what I know, you'd be terrified too." Something huge is headed ...InvestorPlace | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredNext opportunity for crypto millionsAll the Pieces Falling into Place for Crypto… Unlock the Potential of the 2024 Crypto Bull Run!Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.